A phase IIa trial of the new tuberculosis vaccine, MVA85A, in HIV- and/or Mycobacterium tuberculosis-infected adults.

A phase IIa trial of the new tuberculosis vaccine, MVA85A, in HIV- and/or Mycobacterium tuberculosis-infected adults.

RATIONALE: Novel tuberculosis (TB) vaccines should be safe and effective in populations infected with Mycobacterium tuberculosis (M.tb) and/or HIV for effective TB control. OBJECTIVE: To determine the safety and immunogenicity of MVA85A, a novel TB vaccine, among M.tb- and/or HIV-infected persons in...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Scriba, T, Tameris, M, Smit, E, van der Merwe, L, Hughes, E, Kadira, B, Mauff, K, Moyo, S, Brittain, N, Lawrie, A, Mulenga, H, de Kock, M, Makhethe, L, Janse van Rensburg, E, Gelderbloem, S, Veldsman, A, Hatherill, M, Geldenhuys, H, Hill, A, Hawkridge, A, Hussey, G, Hanekom, W, McShane, H, Mahomed, H
Μορφή:	Journal article
Γλώσσα:	English
Έκδοση:	2012

Παρόμοια τεκμήρια

Dose-finding study of the novel tuberculosis vaccine, MVA85A, in healthy BCG-vaccinated infants.
ανά: Scriba, T, κ.ά.
Έκδοση: (2011)

Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in healthy adults in South Africa.
ανά: Hawkridge, T, κ.ά.
Έκδοση: (2008)

The role of clinical symptoms in the diagnosis of intrathoracic tuberculosis in young children
ανά: Mcshane, H, κ.ά.
Έκδοση: (2015)

Modified vaccinia Ankara-expressing Ag85A, a novel tuberculosis vaccine, is safe in adolescents and children, and induces polyfunctional CD4+ T cells.
ανά: Scriba, T, κ.ά.
Έκδοση: (2010)

Risk of disease after isoniazid preventive therapy for mycobacterium tuberculosis exposure in young HIV uninfected children
ανά: Mcshane, H, κ.ά.
Έκδοση: (2015)

Lessons learnt from the first efficacy trial of a new infant tuberculosis vaccine since BCG.
ανά: Tameris, M, κ.ά.
Έκδοση: (2013)

Lessons learnt from the first efficacy trial of a new infant tuberculosis vaccine since BCG
ανά: Tameris, M, κ.ά.
Έκδοση: (2013)

Human newborn bacille Calmette–Guérin vaccination and risk of tuberculosis disease: a case-control study
ανά: Fletcher, H, κ.ά.
Έκδοση: (2016)

Elevated IgG responses in infants are associated with reduced prevalence of Mycobacterium tuberculosis infection
ανά: Logan, E, κ.ά.
Έκδοση: (2018)

Serial QuantiFERON testing and tuberculosis disease risk among young children: an observational cohort study
ανά: Andrews, J, κ.ά.
Έκδοση: (2017)

Effects of MVA85A vaccine on tuberculosis challenge in animals: systematic review
ανά: Mcshane, H, κ.ά.
Έκδοση: (2016)

Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial.
ανά: Tameris, MD, κ.ά.
Έκδοση: (2013)

Heterologous vaccination against human tuberculosis modulates antigen-specific CD4+ T-cell function.
ανά: Dintwe, O, κ.ά.
Έκδοση: (2013)

Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: A randomised, placebo-controlled phase 2b trial
ανά: Tameris, MD, κ.ά.
Έκδοση: (2013)

Inflammation and immune activation are associated with risk of Mycobacterium tuberculosis infection in BCG-vaccinated infants
ανά: Satti, I, κ.ά.
Έκδοση: (2022)

Impact of isoniazid preventive therapy on the evaluation of long-term effectiveness of infant MVA85A vaccination
ανά: Bunyasi, E, κ.ά.
Έκδοση: (2017)

A New Vaccine for Tuberculosis: The Challenges of Development and Deployment
ανά: Fletcher, H, κ.ά.
Έκδοση: (2009)

The candidate TB vaccine, MVA85A, induces highly durable Th1 responses.
ανά: Tameris, M, κ.ά.
Έκδοση: (2014)

Comparison of haematology and biochemistry parameters in healthy South African infants with laboratory reference intervals.
ανά: Schmidt, B, κ.ά.
Έκδοση: (2017)

The candidate TB vaccine, MVA85A, induces highly durable Th1 responses
ανά: Tameris, M, κ.ά.
Έκδοση: (2014)

Clinical testing of tuberculosis vaccine candidates
ανά: Hatherill, M, κ.ά.
Έκδοση: (2016)

Safety and immunogenicity of newborn MVA85A vaccination and selective, delayed Bacille Calmette-Guerin (BCG) for infants of HIV infected mothers: A phase 2 randomized controlled trial.
ανά: Nemes, E, κ.ά.
Έκδοση: (2017)

A comparison of IFNgamma detection methods used in tuberculosis vaccine trials.
ανά: Beveridge, N, κ.ά.
Έκδοση: (2008)

Tuberculosis is changing
ανά: Walker, T, κ.ά.
Έκδοση: (2017)

Antibodies and tuberculosis
ανά: Jacobs, A, κ.ά.
Έκδοση: (2016)

Vaccines for tuberculosis
ανά: McShane, H
Έκδοση: (2013)

Tuberculosis vaccines: progress and challenges.
ανά: Checkley, A, κ.ά.
Έκδοση: (2011)

Tuberculosis vaccines: present and future.
ανά: Minassian, A, κ.ά.
Έκδοση: (2008)

The SIGLEC14 null allele is associated with Mycobacterium tuberculosis- and BCG-induced clinical and immunologic outcomes
ανά: Graustein, A, κ.ά.
Έκδοση: (2017)

Undiagnosed pulmonary tuberculosis among prisoners in Malaysia: an overlooked risk for tuberculosis in the community
ανά: Al-Darraji, H.A.A., κ.ά.
Έκδοση: (2016)

Tuberculosis vaccines: Progress and challenges
ανά: Checkley, A, κ.ά.
Έκδοση: (2011)

Human and Bovine Tuberculosis
ανά: McShane, H
Έκδοση: (2016)

The future of vaccines for tuberculosis
ανά: Stockdale, L, κ.ά.
Έκδοση: (2019)

Immunological outcomes of new tuberculosis vaccine trials: WHO panel recommendations.
ανά: Hanekom, W, κ.ά.
Έκδοση: (2008)

Prime-boost immunisation strategies for tuberculosis.
ανά: Mcshane, H, κ.ά.
Έκδοση: (2005)

Tuberculosis vaccine promises sterilizing immunity.
ανά: Mcshane, H, κ.ά.
Έκδοση: (2011)

Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in Mycobacterium tuberculosis-infected individuals.
ανά: Sander, C, κ.ά.
Έκδοση: (2009)

Immunological outcomes of new tuberculosis vaccine trials: WHO panel recommendations
ανά: Hanekom, W, κ.ά.
Έκδοση: (2008)

Process of Assay Selection and Optimization for the Study of Case and Control Samples from a Phase IIb Efficacy Trial of a Candidate Tuberculosis Vaccine, MVA85A
ανά: Harris, SA, κ.ά.
Έκδοση: (2014)

Generation and analysis of attack graphs on computer networks
ανά: Janse van Rensburg, A
Έκδοση: (2018)